UCB Reinforces Commitment to Rheumatology With 15 Abstracts Including New Late-Breaking Data at ACR Convergence 2022

/PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that it will present 15 abstracts across its rheumatology portfolio at ACR Convergence...

Related Keywords

United Kingdom ,Brussels ,Bruxelles Capitale ,Belgium ,Philadelphia ,Pennsylvania ,United States ,Smyrna ,Izmir ,Turkey ,Great Britain ,Nicole Herga ,Emmanuel Caeymaex ,J Clin Pharmacol ,Antje Witte ,Immunology Solutions ,Twitter ,Bimekizumab Treatment Improves Health ,Ucb Inc ,Drug Administration ,Group Of Companies ,European Union Eu Economic Area ,Us Immunology Communications ,Source Ucb Inc ,Executive Vice President ,Psoriatic Arthritis ,Active Psoriatic Arthritis ,Week Efficacy ,Safety Results ,Active Reference ,Inadequate Response ,Tumor Necrosis Factor Inhibitors ,Treatment Improves Health Related Quality ,Active Psa ,Week Results From Two Phase ,Disease Activity Assessed ,Composite Endpoints ,Week Results ,Treatment Results ,Two Phase ,Greater Improvements ,Patient Centric Measures ,Physical Function ,Maintains Improvements ,Efficacy Endpoints ,Consistent Safety Profile Through ,Non Radiographic Axial Spondyloarthritis ,Ankylosing Spondylitis ,Two Parallel Phase ,Improves Signs ,Including Inflammation ,Active Non Radiographic Axial Spondyloarthritis ,Active Ankylosing Spondylitis ,Safety From ,Placebo Controlled ,Improves Key Patient Reported Symptoms ,Axial Spondyloarthritis Including Spinal Pain ,Improves Physical Function ,Health Related Quality ,Axial Spondyloarthritis ,Results From Two Phase ,Increasingly Stringent Clinical Response Criteria ,Lower Levels ,Patients With Active Axial Spondyloarthritis ,Exploratory Analysis ,Clinical Response ,Certolizumab Pegol Treatment ,Active Axial ,Term Clinical Outcomes ,Active Non ,Radiographic Axial Spondyloarthritis Stratified ,C Reactive Protein ,Preliminarily Proposed ,Sacroiliac Joints ,Axial Spondyloarthritis Patients ,European Union ,European Economic Area ,Euronext Brussels ,Product Characteristics ,